Key facts
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G/A for ALDEYRA THERAPEUTICS, INC. Common Stock, par value $0.001 per share (ALDX).
- Disclosed ownership: 8.2%.
- Date of event: 03 Apr 2025.
PERCEPTIVE ADVISORS LLC - 03 Apr 2025 SCHEDULE 13G/A Report for ALDEYRA THERAPEUTICS, INC. Common Stock, par value $0.001 per share (ALDX)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- ALDX
- Shares outstanding
- 59,461,598 shares
- Disclosed Ownership
- 4,875,851 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 07 Apr 2025, 18:52:21 UTC
- Date of event
- 03 Apr 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Key filing fact
PERCEPTIVE ADVISORS LLC disclosed 8.2% ownership in ALDEYRA THERAPEUTICS, INC. Common Stock, par value $0.001 per share (ALDX) on 03 Apr 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 07 Apr 2025, 18:52.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 8.2% | 4,875,851 | 0 | 4,875,851 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 8.2% | 4,875,851 | 0 | 4,875,851 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Perceptive Life Sciences Master Fund, Ltd. | 8.2% | 4,875,851 | 0 | 4,875,851 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |
CIK / CUSIP context first